Whether you’re interested in tracking misinformation, flagging misinformation, or just want to show support for vaccines and science, you are needed now more than ever.
Category Archives: AZBio News
Ashion Analytics announces innovative cancer treatment partnership with Elevation Oncology
Ashison Analytics GEMExTra test detects rare NRG1 gene fusions in patients whose cancer is driven by this genomic alteration for potential matching to a clinical trialContinue reading
Patients, Employers, Labs and Health Insurance Providers Call on Congress to Dedicate Funding for COVID-19 Testing to Get America Back to Work and School
WASHINGTON, D.C. – The National Consumers League, the American Clinical Laboratory Association (ACLA) and America’s Health Insurance Plans (AHIP) joined nearly 50 leading stakeholders representing patients, employers, clinical laboratories, health insurance providers and other leaders from across health care community yesterday in sending a letter to congressional leadership requesting dedicated federal funding for the critical testing needed to reopen the country.Continue reading
First Results from Field Study of RenoVō® Equine Allograft Released
Equine Amnio Solutions, LLC (EAS), a distributor of advanced, next-generation regenerative products derived from amniotic birth tissues, announced today first results from a large field study of RenoVō® for soft tissue and orthopedic horse injuries.
Pfizer and BioNTech Announce Agreement with U.S. Government for up to 600 Million doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
U.S. government placed an initial order of 100 million doses for $1.95 billion and can acquire up to 500 million additional doses
Americans to receive the vaccine for free consistent with U.S. government’s commitment for free access for COVID-19 vaccines
Pfizer and BioNTech remain on track to begin an anticipated Phase 2b/3 safety and efficacy trial later this month, seek regulatory review as early as October 2020, and manufacture globally up to 100 million doses by the end of 2020 and potentially more than 1.3 billion doses by the end of 2021Continue reading
AZBio Releases RFP To Engage a Fundraising Consultant for AZAdvances
The Arizona Bioindustry Association, Inc. (AZBio) is issuing this Request for Proposals (RFP) to qualified firms to provide fundraising services to support the capitalization of the Arizona endowment within AZAdvances (www.azadvances.org). AZAdvances is a division of the Opportunity Through Entrepreneurship Foundation, a 501c3 public charity with offices at 107 S Southgate Drive, Chandler, AZ 85226.Continue reading
Applications for the Arizona Innovation Challenge Open August 3rd
PHOENIX, AZ (July 17, 2020) — The Arizona Commerce Authority (ACA) announced today applications are being accepted for the 2020 Arizona Innovation Challenge (AIC) beginning Monday, August 3rd. The business plan competition is designed to advance innovation and technology commercialization opportunities in Arizona by helping early-stage ventures scale.Continue reading
Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
- Portfolio of 15 generic and over-the-counter (OTC) medicines from Sandoz division addresses urgent unmet needs of low- and lower-middle-income countries to treat patients with COVID-19 symptoms
- Portfolio will be sold at zero-profit to governments in up to 791 eligible countries during the pandemic and until a vaccine or curative treatment is available
- Early access to treatment for managing COVID-19 symptoms is critical to preventing healthcare system overload
Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273)
Interim analysis of original cohorts of Phase 1 study evaluated two-dose vaccination schedule of mRNA-1273 across three dose levels (25, 100, 250 µg) in 45 healthy adults ages 18-55 years; results reaffirm and expand upon positive interim data announced on May 18thContinue reading
C-Path Data Collaboration Center Analytics Team Wins Metadata Automation DREAM Challenge
TUCSON, Ariz., July 14, 2020 — Tucson-based Critical Path Institute (C-Path) today proudly announced that the analytics team from its Data Collaboration Center (DCC) program has won first place in the validation phase of the Metadata Automation DREAM Challenge, funded by the Cancer Moonshot℠ initiative. The mission of C-Path’s DCC program is to provide large-scale data collaboration solutions to support scientific research and advance medical innovation.Continue reading